메뉴 건너뛰기
Alimentary Pharmacology and Therapeutics
Volumn 32, Issue 1, 2010, Pages 116-117
Anti TNF-α therapy can be a novel treatment option in patients with autoimmune hepatitis: Authors' reply
Author keywords

[No Author keywords available]
Indexed keywords

CORTICOSTEROID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
EID: 77953212629     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04325.x     Document Type: Letter
Times cited : (3)
References (9)
  • 1
    • 77953183219 scopus 로고    scopus 로고
    • Anti TNF-α therapy can be a novel treatment option in patients with autoimmune hepatitis
    • Efe C, Purnak T, Ozaslan E. Anti TNF-α therapy can be a novel treatment option in patients with autoimmune hepatitis. Aliment Pharmacol Ther 2010 32 : 115.
    • (2010) Aliment Pharmacol Ther , vol.32 , pp. 115
    • Efe, C.1    Purnak, T.2    Ozaslan, E.3
  • 3
    • 0028819043 scopus 로고
    • Circulating level of interleukin-6, interleukin-8 and tumour necrosis factor-alpha in children with autoimmune hepatitis
    • Maggiore G, Bennedetti F, Massa M, et al. Circulating level of interleukin-6, interleukin-8 and tumour necrosis factor-alpha in children with autoimmune hepatitis. J Paediatr Gastroenterol Nutr 1995 20 : 23 7.
    • (1995) J Paediatr Gastroenterol Nutr , vol.20 , pp. 23-7
    • Maggiore, G.1    Bennedetti, F.2    Massa, M.3
  • 4
    • 0032862558 scopus 로고    scopus 로고
    • Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis
    • Cookson S, Constantini PK, Clare M, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999 30 : 851 856.
    • (1999) Hepatology , vol.30 , pp. 851-856
    • Cookson, S.1    Constantini, P.K.2    Clare, M.3
  • 5
    • 0032819862 scopus 로고    scopus 로고
    • Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis
    • Czaja AJ, Cookson S, Constantini PK, et al. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 1999 117 : 645 652.
    • (1999) Gastroenterology , vol.117 , pp. 645-652
    • Czaja, A.J.1    Cookson, S.2    Constantini, P.K.3
  • 6
    • 72049102386 scopus 로고    scopus 로고
    • A case of difficult to treat autoimmune hepatitis successfully managed b TNFR-alpha blockade
    • Weiler-Normann C, Wiegard C, Schramm C, et al. A case of difficult to treat autoimmune hepatitis successfully managed b TNFR-alpha blockade. Am J Gastroenterol 2009 104 : 2877 2878.
    • (2009) Am J Gastroenterol , vol.104 , pp. 2877-2878
    • Weiler-Normann, C.1    Wiegard, C.2    Schramm, C.3
  • 7
    • 31644443300 scopus 로고    scopus 로고
    • Use of etancercept in a the treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis
    • Goldenberg G, Jorizzo JL. Use of etancercept in a the treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis. J Dermatolog Treat 2005 16 : 347 349.
    • (2005) J Dermatolog Treat , vol.16 , pp. 347-349
    • Goldenberg, G.1    Jorizzo, J.L.2
  • 8
    • 33847686821 scopus 로고    scopus 로고
    • Serious liver disease induced by infliximab
    • Tobon GJ, Canas C, Jaller JJ, et al. Serious liver disease induced by infliximab. Clin Rheumatol 2007 26 : 578 581.
    • (2007) Clin Rheumatol , vol.26 , pp. 578-581
    • Tobon, G.J.1    Canas, C.2    Jaller, J.J.3
  • 9
    • 72149112759 scopus 로고    scopus 로고
    • Autoimmune diseases induced by biological agents: A double-edged sword?
    • Ramos-Casals M, Perez-Alvarez R, Diaz-Lagares C, et al. Autoimmune diseases induced by biological agents: A double-edged sword? Autoimmun Rev 2010 9 : 188 193.
    • (2010) Autoimmun Rev , vol.9 , pp. 188-193
    • Ramos-Casals, M.1    Perez-Alvarez, R.2    Diaz-Lagares, C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.